Filing Details
- Accession Number:
- 0001209191-18-063896
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-12-21 16:11:45
- Reporting Period:
- 2018-12-06
- Accepted Time:
- 2018-12-21 16:11:45
- Original Submission Date:
- 2018-12-10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1691005 | Gatti Susanna High | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-06 | 15 | $68.65 | 15,625 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-12-06 | 475 | $104.13 | 15,150 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-06 | 1,100 | $106.11 | 14,050 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-12-06 | 300 | $106.70 | 13,750 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-12-06 | 15 | $0.00 | 15 | $68.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 40,647 | 2026-12-01 | No | 4 | M | Direct |
Footnotes
- This Form 4 amendment is being filed to report the exercise of 15 stock options which was inadvertently omitted from the original Form 4 filed by the reporting person on December 10, 2018.
- The reporting person's amount of securities beneficially owned following the reporting transaction is amended to reflect the accurate amount owned.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on December 18, 2017.
- The range in prices for the transaction reported on this line was $104.01 to $104.29. The average weighted price was $104.1333. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $105.50 to $106.49. The average weighted price was $106.1123. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The range in prices for the transaction reported on this line was $106.51 to $107.42. The average weighted price was $106.7042. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- This option vests over a four-year period at a rate of twenty-five percent (25%) on November 30, 2017, and in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
